Large-scale clinical trials and other research are “urgently required” to determine the best ways to manage the growing number of…
Articles by Marisa Wexler, MS
A branch of the European Medicines Agency (EMA) has recommended expanding Kaftrio (ivacaftor/tezacaftor/elexacaftor), in combination with Kalydeco (ivacaftor), to include children…
People with cystic fibrosis (CF) who have mild depression or anxiety report heightened…
Use of inhaled hypertonic saline can lessen cystic fibrosis (CF)-related lung damage in young children with the disease, data from…
Trikafta treatment can reduce the frequency of pulmonary exacerbations — times when lung symptoms get markedly worse — for…
Personalized treatment with bacteria-infecting viruses, called bacteriophages, could be used to combat Pseudomonas aeruginosa, the main bacteria involved in…
Treatment with Trikafta may improve nutritional status or lessen anemia among some people with cystic fibrosis (CF) who…
Treatment with Trikafta lowered the need for antibiotics and mucus-clearing therapies among children…
Treatment with Trikafta rapidly eases symptoms of chronic nose and sinus inflammation in…
Treatment with Trikafta improves lung function in people with cystic fibrosis (CF) who are not eligible for treatment…